GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
GSK’s ex-vaccines chief says its jab for a flu-like virus is too expensive
GSK’s ex-head of vaccines says its blockbuster jab for a flu-like virus that spreads in the autumn and winter is too ...
manilatimes3d
GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia
Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy ...
Sportskeeda3d
"The Great One is now pimping big pharma": NHL fans displeased with Wayne Gretzky's new commercial for AREXVY vaccine
NHL fans displeased with Wayne Gretzky's new commercial for AREXVY vaccine. (Image Source: Imagn). NHL fans have expressed their dissatisfaction on social media regarding Wayne Gretzky's latest ...
Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...
LancasterOnline2d
GSK expansion project in East Donegal Township could get a tax break
East Donegal Township is considering a tax break that would benefit an expansion of the GSK vaccine packaging facility in ...
FiercePharma2d
American Lung Association sounds alarm and launches new GSK-backed RSV campaign amid low vax rates
As the Centers for Disease Control and Prevention (CDC) finds that only one-quarter of older adults have received their ...
Managed Healthcare Executive5d
RSV Vaccine Keeps Older People Out of the Hospital
Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...